Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

MBX Biosciences (MBX) Shares Outstanding (Diluted Average) (2023 - 2026)

MBX Biosciences has reported Shares Outstanding (Diluted Average) over the past 4 years, most recently at $46.6 million for Q1 2026.

  • Quarterly results put Shares Outstanding (Diluted Average) at $46.6 million for Q1 2026, up 39.4% from a year ago — trailing twelve months through Mar 2026 was $46.6 million (up 39.4% YoY), and the annual figure for FY2025 was $36.5 million, up 243.01%.
  • Shares Outstanding (Diluted Average) reached $46.6 million in Q1 2026 per MBX's latest filing, up from $36.5 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $46.6 million in Q1 2026 and bottomed at $1.0 million in Q4 2023.
  • Median Shares Outstanding (Diluted Average) over the past 4 years was $10.6 million (2024), compared with a mean of $18.3 million.
  • The largest annual shift saw Shares Outstanding (Diluted Average) skyrocketed 2678.82% in 2025 before it skyrocketed 39.4% in 2026.
  • Over 4 years, Shares Outstanding (Diluted Average) stood at $1.0 million in 2023, then soared by 944.7% to $10.6 million in 2024, then skyrocketed by 243.01% to $36.5 million in 2025, then increased by 27.58% to $46.6 million in 2026.
  • Business Quant data shows Shares Outstanding (Diluted Average) for MBX at $46.6 million in Q1 2026, $36.5 million in Q4 2025, and $33.7 million in Q3 2025.